Nephrocare Heal.

Not Rated
  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
451.90
-9.8 (-2.12%)
BSENSE

Dec 19

BSE+NSE Vol: 8.85 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Nephrocare Heal. Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
No of Months
12
12
12
12
Profit Before Tax
87.00
33.00
-8.00
-27.00
Adjustment
93.00
80.00
68.00
64.00
Changes In working Capital
-44.00
-33.00
-53.00
-18.00
Cash Flow after changes in Working Capital
136.00
80.00
6.00
19.00
Cash Flow from Operating Activities
135.00
72.00
11.00
14.00
Cash Flow from Investing Activities
-125.00
-51.00
-75.00
-129.00
Cash Flow from Financing Activities
54.00
26.00
59.00
121.00
Net Cash Inflow / Outflow
64.00
47.00
-4.00
6.00
Opening Cash & Cash Equivalents
61.00
14.00
18.00
12.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
125.00
61.00
14.00
18.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Nephrocare Heal.
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
87.44
146.88
-59.00
-40.47%
Adjustment
93.04
73.28
20.00
26.97%
Changes In working Capital
-44.17
12.54
-56.00
-452.23%
Cash Flow after changes in Working Capital
136.3
232.7
-96.00
-41.43%
Cash Flow from Operating Activities
135.35
191.32
-56.00
-29.25%
Cash Flow from Investing Activities
-125.05
-52.52
-73.00
-138.10%
Cash Flow from Financing Activities
54.37
-130.42
184.00
141.69%
Net Cash Inflow / Outflow
64.67
8.38
56.00
671.72%
Opening Cash & Cash Equivalents
61.15
9.3
52.00
557.53%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
125.82
17.68
108.00
611.65%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is 87.26% vs 541.35% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
135.35
72.28
87.26%